24/7 life science manufacturing IT service launches
Faster GMP incident response and resolution times when manufacturing IT applications fail or are not running to their optimum capacity.
Zenith Technologies has launched and rolled out a global 24/7 manufacturing IT support service specially designed to meet the needs of the life science industry.
Sitting as part of Zenith’s services division, the manufacturing IT team provides high-quality multi-platform engineering support across automation, manufacturing execution systems (MES), digital and lab IT systems.
It offers a single point of contact with faster GMP incident response and resolution times when manufacturing IT applications fail or are not running to their optimum capacity.
David Staunton, director global services at Zenith Technologies, states: “The continuing demand for automation, MES and digital solutions in the life science industry is creating an urgent need for specialist manufacturing IT support. Zenith is perfectly positioned to deliver this as the business has a deep understanding of GMP manufacturing systems and their support applications.
“There’s a strong business case for outsourcing this support as it opens up a depth of knowledge that can’t be achieved alone. For example, if you have one syringe filling machine on your site, your machine’s vendor may have 300 across the market, possessing a level of knowledge that no single customer could achieve alone.
“A close alliance with your vendor, therefore, makes perfect sense to facilitate faster GMP response times, high-quality root cause analysis and reduction of repeating incidents. Zenith works with the leading life science companies globally and has unrivalled knowledge across multiple platforms.
“Having a single point of contact for all applications is also a real advantage to our customers, who get access to the Zenith global resource hub for incident resolution and business improvement strategies.”
The service is designed for life science manufacturers and can be offered onsite, remotely or a combined approach to suit the customer shift support needs. It provides analytical support directly to the end customer, with queries routed to a hub of specialist engineers when required.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance